LSI: “It’s Women’s Health Awareness Month, and we’re highlighting a new women’s health company each day in May. Today we’re highlighting Choice – Female Proconception, led by CEO Peter Van De Graaf.

Choice has developed small, implantable, wirelessly controlled valves as a contraceptive. Placed in a short, outpatient procedure, without the need for surgery, Choice valves open or close the fallopian tubes.

Outside of the short moments when the valves are opened or closed, the Choice system contains no active electronics. The Choice system also contains no batteries. Choice works as a reversible sterilization system. It simply blocks the tubes, unless a woman decides otherwise. It contains no hormones or other active chemical components.

Visit our website to watch Peter’s recent presentation and learn more about how Choice is developing a hormone-free female contraceptive.”